Vasopressin-receptor antagonist therapy in patients with hyponatraemia.
Hyponatraemia often complicates the treatment of underlying conditions in patients who are seriously ill. Arginine vasopressin receptor antagonists block the action of arginine vasopressin and correct sodium and water imbalance in patients with euvolaemic or hypervolaemic hyponatraemia.
Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Tushar
T
Vachharajani
Vidula
V
Vachharajani
D000368:Aged; D065092:Antidiuretic Hormone Receptor Antagonists; D005355:Fibrosis / Q000150:complications; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy*; D007037:Hypothyroidism / Q000150:complications; D014869:Water Intoxication / Q000150:complications
D065092:Antidiuretic Hormone Receptor Antagonists